货号：UP782664613
| 产品信息 | |
| 产品名称： | MBQ-167 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 2097938-73-1 |
| 分子式： | C22H18N4 |
| 分子量： | 338.41 |
| MDL NO： | N/A |
| 标准纯度： | 98+% (UP782664613) |
| 沸点： | - |
| 储存： | (UP782664613) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
TAK-733
UP9424516361035555-63-5
DL-Histidine
UP6040201424998-57-6
R(+)-IAA-94
UP47609155654197-31-8
MK-0893
UP934606238870823-12-4
Suloctidil
UP20661059754767-75-8
RAF265
UP661067803927880-90-8
Alrestatin sodium
UP61315263251876-97-2
Pracinostat
UP174691929929016-96-6
EHT 1864
UP647753180754240-09-0
CMK
UP846339860821794-90-5
L-Phenylalanine
UP67749907063-91-2
Fomepizole
UP1309845037554-65-6
APS-2-79 hydrochloride
UP6201759072002381-31-7
Tetrabenazine (+)-
UP3440129821026016-83-0
Dantrolene sodium hemiheptahydrate
UP55393720124868-20-0
FMK
UP264278495821794-92-7
2-(3,5-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
UP51738256668716-51-8
2-Amino-4-chloro-5-methylbenzenesulfonic acid
UP66498806188-51-7
N-(2-((2,6-Dicyano-4-nitrophenyl)diazenyl)-5-(diethylamino)phenyl)acetamide
UP29238561941642-51-7
1,3-Dihydrobenzo[c]isothiazole 2,2-dioxide
UP219606547111248-89-6
1-(Chloromethyl)-3,5-difluorobenzene
UP445216664220141-71-9
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
UP901669692380151-86-0
I-BRD9
UP2314508221714146-59-4
AZ505 ditrifluoroacetate
UP3255172651035227-44-1
Estrone
UP15982689153-16-7
PD98059
UP807565081167869-21-8
2-(4-(2,2-Difluoroethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
UP287266478864754-48-3
1-Chloro-4-(chloromethyl)-2,3-difluorobenzene
UP1489877511807133-11-4
Regadenoson
UP938094052313348-27-5
UNC0638
UP2072128601255580-76-7
GDC-0068
UP6725708531001264-89-6
UNC1215
UP4766655861415800-43-9
4',5'-Dichloro-3',6'-dihydroxy-2',7'-dimethoxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-5-carboxylic acid
UP578930865082855-39-8
C60 Fullerene
UP71903359299685-96-8
XAV-939
UP449414412284028-89-3
Esuberaprost
UP43115556694132-88-4
PPQ-102
UP310478675931706-15-9
PLX4720
UP511249934918505-84-7
Methocarbamol
UP661985654532-03-6
2-Fluoro-4-(methoxycarbonyl)phenylboronic acid
UP177619969603122-84-5
Kasugamycin
UP9371143726980-18-3
Jujuboside D
UP896685068194851-84-8
CMPDA
UP642566631380607-77-2
1-Amino-2-methylanthracene-9,10-dione
UP44772595982-28-0
Cobimetinib
UP627722551934660-93-2
Fmoc-Phe-Gly
UP579544106169624-67-3
6-((4,6-Dichloro-1,3,5-triazin-2-yl)amino)-3',6'-dihydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one hydrochloride
UP8146144894118357-32-7
PE859
UP9804140641402727-29-0
SCH772984
UP166203569942183-80-4
Rotenone
UP57014579283-79-4
Enprostil
UP72567241173121-56-9
Acefylline
UP734078845652-37-9
O4I1
UP176444078175135-47-4
Equol
UP927055009531-95-3
B-Raf inhibitor 1 dihydrochloride
UP7413374981191385-19-9
Pentane-1,5-diol
UP246842675111-29-5
2-(Diethoxyphosphoryl)acetic acid
UP4229563803095-95-2
glucagon receptor antagonists-1
UP316578157503559-84-0
ALW-II-41-27
UP6895871531186206-79-0
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
UP499255803486460-21-3
GLPG1690
UP4552943521628260-79-6
Z-Glu-OBzl
UP8595149483705-42-8
Irinotecan hydrochloride trihydrate
UP337760585136572-09-3
Opicapone
UP687733119923287-50-7
BMS-823778
UP6535521181140898-87-8
AZD5363
UP9767437961143532-39-1
DC_05
UP222552199890643-16-0
EPZ-5676
UP7655250691380288-87-8
EPZ004777
UP2655696841338466-77-5
Glutathione
UP13239536470-18-8
OAC1
UP456518506300586-90-7
XMD8-92
UP2634406511234480-50-2
Dienogest
UP88996264565928-58-7
4,4'-Bis(hexyloxy)-3-methylazobenzene
UP19583032101440509-03-4
Ivacaftor hydrate
UP6738126811134822-07-3
4,4'-Dihydroxybiphenyl
UP22286907492-88-6
Progesterone
UP99936065757-83-0
(Z)-Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate
UP8424264291234321-81-3
I-BET-762
UP6516626631260907-17-2
2,3,3-Trimethylindolenine
UP6767009461640-39-7
Mifepristone
UP62698283684371-65-3
TAS-103 dihydrochloride
UP874735507174634-09-4
Naspm trihydrochloride
UP3426244451049731-36-3
Fluticasone propionate
UP59526987780474-14-2
MBQ-167
UP7826646132097938-73-1